Y-Med Pharmaceutical
Location
x,
Ho Chi Minh City, x,
Vietnam
Website
https://www.y-med.asia/
Phone
84842838266819
Artw industry
Professional Services
Employee
Revenue

Y-Med Pharmaceutical Technographics

Y-Med Pharmaceutical Software Purchases and Digital Transformation Initiatives

Discover the latest software purchases and digital transformation initiatives being undertaken by Y-Med Pharmaceutical and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 Y-Med Pharmaceutical employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Y-Med Pharmaceutical has purchased the following applications: Microsoft 365 for Collaboration in 2022, Imunify360 for Web Application Firewalls (WAF) in 2023 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Y-Med Pharmaceutical is running and its propensity to invest more and deepen its relationship with Microsoft , CloudLinux or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Y-Med Pharmaceutical revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Y-Med Pharmaceutical intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

Y-Med Pharmaceutical Data, Technology Stack, and Enterprise Applications
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2022 2022
CyberSecurity
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
CloudLinux Legacy Imunify360 Web Application Firewalls (WAF) CyberSecurity n/a 2023 2023
IT Decision Makers and Key Stakeholders at Y-Med Pharmaceutical
First Name Last Name Title Function Department Email Phone
No data found
Show All Contacts
Apps Being Evaluated by Y-Med Pharmaceutical Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Y-Med Pharmaceutical Technographics

Y-Med Pharmaceutical is a Professional Services organization based in Vietnam, with around 10 employees and annual revenues of $2.0 million.

Y-Med Pharmaceutical operates a diverse technology stack with applications such as Microsoft 365 and Imunify360, covering areas like Collaboration and Web Application Firewalls (WAF).

Y-Med Pharmaceutical has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft and CloudLinux.

Y-Med Pharmaceutical recently adopted applications including Imunify360 in 2023 and Microsoft 365 in 2022, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Y-Med Pharmaceutical’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Y-Med Pharmaceutical’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Y-Med Pharmaceutical technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.